ABIVAX (EPA:ABVX) | WebDisclosure

Basculer en Français

8295	Companies
114809	Keywords
55260	Articles
62422	Press releases

Home
Companies
ABIVAX

BRIEF

published on 11/19/2024 at 22:35, 1 day 10 hours ago

Abivax Launches ATM Program on Nasdaq

Common Shares Biotechnology Funding Nasdaq ATM Program
BRIEF

published on 11/19/2024 at 22:35, 1 day 10 hours ago

Abivax lance un programme ATM sur le Nasdaq

Biotechnologie Financement Nasdaq Actions Ordinaires Programme ATM
PRESS RELEASE

published on 11/19/2024 at 22:30, 1 day 11 hours ago

Abivax met en place un programme « At-the-Market (ATM) » sur le Nasdaq
Abivax met en place un programme 'At-the-Market (ATM)' sur le Nasdaq pour émettre et vendre des actions ordinaires pour financer ses programmes cliniques et besoins généraux

Biotechnologie Abivax Nasdaq Programme ATM At-the-Market
PRESS RELEASE

published on 11/19/2024 at 22:30, 1 day 11 hours ago

Abivax Establishes an At-the-Market (ATM) Program on Nasdaq
Abivax establishes an At-the-Market (ATM) Program on Nasdaq, allowing issuance and sale of ordinary shares to raise up to $150 million. Implementation involves Piper Sandler & Co. as sales agent

Ordinary Shares Abivax Nasdaq ATM Program Piper Sandler
PRESS RELEASE

published on 11/19/2024 at 22:30, 1 day 11 hours ago

Abivax met en place un programme « At-the-Market (ATM) » sur le Nasdaq
Abivax met en place un programme 'At-the-Market (ATM)' sur le Nasdaq pour émettre des actions ordinaires, offrant jusqu'à 150M$, grâce à un contrat avec Piper Sandler, pour financer ses programmes cliniques

Abivax Nasdaq Émission D'actions Programme ATM Piper Sandler
BRIEF

published on 11/14/2024 at 22:06, 6 days 11 hours ago

Abivax publie ses résultats financiers du troisième trimestre 2024

Résultats Financiers Biotechnologie Abivax Rectocolite Hémorragique 3e Trimestre 2024
BRIEF

published on 11/14/2024 at 22:06, 6 days 11 hours ago

Abivax Releases Q3 2024 Financial Results

Financial Results Biotechnology Abivax Ulcerative Colitis Q3 2024
PRESS RELEASE

published on 11/14/2024 at 22:01, 6 days 11 hours ago

Abivax présente les principales informations financières du troisième trimestre 2024
Abivax présente les principales informations financières du troisième trimestre 2024, avec une trésorerie de 180,5 millions d'euros et une dette restante de 106,3 millions d'euros. La Société prévoit de financer ses activités jusqu'au quatrième trimestre 2025

Abivax Information Financière Trésorerie Trimestre 2024 Dette Restante
PRESS RELEASE

published on 11/14/2024 at 22:01, 6 days 11 hours ago

Abivax presents third quarter 2024 key financial information
Abivax presents key financial information for the third quarter of 2024. The company announced updates on operational goals and debt status. Details on Abivax's cash and principal debt outstanding are provided

Financial Information Abivax Quarter Results Clinical-stage Biotechnology Debt Status
PRESS RELEASE

published on 11/14/2024 at 22:01, 6 days 11 hours ago

Abivax présente les principales informations financières du troisième trimestre 2024
Abivax présente les informations financières du troisième trimestre 2024, avec une trésorerie de 180,5 millions d'euros et une dette de 106,3 millions d'euros. Détails ici

Abivax Dette Trésorerie Informations Financières Troisième Trimestre

Accesswire

Published on 11/21/2024 at 09:00, 30 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 8 hours 55 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 9 hours 5 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 00:00, 9 hours 30 minutes ago

Swiss Mining Institute Conference Presentation
Published on 11/20/2024 at 23:00, 10 hours 30 minutes ago

Rektron Group Inc. Announces Appointment of a New Director and Provides Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 09:01, 29 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy
Published on 11/21/2024 at 08:59, 30 minutes ago

Black Friday Savings: Kling AI Offers 50% Off and Free Feature Upgrades
Published on 11/21/2024 at 08:59, 30 minutes ago

Économies Black Friday : Kling AI propose 50 % de réduction et des mises à niveau gratuites des fonctionnalités
Published on 11/21/2024 at 08:15, 1 hour 15 minutes ago

EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%.
Published on 11/21/2024 at 08:09, 1 hour 21 minutes ago

KAP HOLDS ITS GROUND IN A DIFFICULT INDUSTRY ENVIRONMENT IN THE FIRST NINE MONTHS OF 2024

Les Echos

Published on 11/21/2024 at 06:58, 2 hours 32 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 32 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 32 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 13 hours 23 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 14 hours 10 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE